Details for Patent: 11,951,190
✉ Email this page to a colleague
Which drugs does patent 11,951,190 protect, and when does it expire?
Patent 11,951,190 protects PLUVICTO and is included in one NDA.
This patent has sixty-three patent family members in twenty-eight countries.
Drugs Protected by US Patent 11,951,190
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | PLUVICTO | lutetium lu-177 vipivotide tetraxetan | SOLUTION;INTRAVENOUS | 215833-001 | Mar 23, 2022 | RX | Yes | Yes | 11,951,190 | ⤷ Subscribe | FOR TREATMENT OF ADULT PATIENTS WITH PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-POSITIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) WHO HAVE BEEN TREATED WITH ANDROGEN RECEPTOR (AR) PATHWAY INHIBITION AND TAXANE-BASED CHEMOTHERAPY | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,951,190
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 4095130 | ⤷ Subscribe | CA 2024 00027 | Denmark | ⤷ Subscribe |
European Patent Office | 4095130 | ⤷ Subscribe | LUC00352 | Luxembourg | ⤷ Subscribe |
European Patent Office | 4095130 | ⤷ Subscribe | 301281 | Netherlands | ⤷ Subscribe |
European Patent Office | 4095130 | ⤷ Subscribe | PA2024522 | Lithuania | ⤷ Subscribe |
European Patent Office | 4095130 | ⤷ Subscribe | 2024C/528 | Belgium | ⤷ Subscribe |
European Patent Office | 4095130 | ⤷ Subscribe | 122024000038 | Germany | ⤷ Subscribe |
Australia | 2014336638 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |